Which painkiller combo works best after hernia repair?
NCT ID NCT07194694
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding dexmedetomidine or ketamine to a standard numbing medicine (bupivacaine) improves pain control after inguinal hernia surgery. Sixty adults received one of three injections into the abdominal wall just before waking up. Researchers measured pain scores and blood pressure over the first 12 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexmedetomidine, ketamine, and bupivacaine
- What this could lead to
- If one additive works better, it could mean longer pain relief after hernia surgery with fewer side effects.
- What could go wrong
- This is a small, single-center trial (60 people). Results may not apply to everyone, and neither additive may prove clearly better than bupivacaine alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
60 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients undergoing unilateral inguinal hernioplasty of ASA I or II. * Age group: 18-60 years old. Exclusion Criteria: * Patient refusal. * known allergy to any of the used drugs * ASA III or above * Coagulation disorders and thrombocytopenia * Body mass index (BMI) \>30 * Infection at needle insertion site * Patients undergoing bilateral inguinal hernioplasty
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postoperative pain relief are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University Hospitals
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.